Table 2 Follow up characteristics
GROUP 1 (n = 60) | GROUP 2 (n = 57) | |||||||
|---|---|---|---|---|---|---|---|---|
FOLLOW UP (months) | t0 | t3 | t6 | t9 | t0 | t3 | t6 | t9 |
Bacterial infections (n, %) | 33 (55.0%) | 1 (1.6%) | 0 (0%) | 2 (3.3%) | 31 (54.4%) | 1 (1.7%) | 0 (0%) | 0 (0%) |
Yeast infections (n, %) | 27 (45.0%) | 3 (5.0%) | 0 (0%) | 7 (11.6%) | 26 (45.6%) | 1 (1.7%) | 0 (0%) | 1 (1.7%) |
PAP smear abnormalities (n, %) | 40 (66.6%) | 28 (46.6%) | – | 25 (41.6%) | 39 (68.4%) | 25 (43.8%) | – | 8 (14.0%) |
HPV DNA+ (n, %) | 55 (91.7%) | – | – | 48 (80.0%) | 51 (89.4%) | – | – | 33 (57.8%) |
Pathologic colposcopy findings (HPV DNA negative) (n, %) | 5 (8.3%) | 2 (3.3%) | 3 (5.0%) | 3 (5.0%) | 6 (10.5%) | 3 (5.2%) | 2 (3.5%) | 0 (0%) |